chr17-46978953-C-T

Variant summary

Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BP4_Strong

The NM_203400.5(RPRML):​c.55G>A​(p.Gly19Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000887 in 1,454,090 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.00049 ( 1 hom., cov: 33)
Exomes 𝑓: 0.000041 ( 0 hom. )

Consequence

RPRML
NM_203400.5 missense

Scores

1
2
16

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 1.28

Publications

0 publications found
Variant links:
Genes affected
RPRML (HGNC:32422): (reprimo like) Predicted to be integral component of membrane. [provided by Alliance of Genome Resources, Apr 2022]
LRRC37A2 (HGNC:32404): (leucine rich repeat containing 37 member A2) Predicted to be integral component of membrane. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -4 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.010610789).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
RPRMLNM_203400.5 linkc.55G>A p.Gly19Ser missense_variant Exon 1 of 1 ENST00000322329.5 NP_981945.1 Q8N4K4
LRRC37A2XM_024450773.2 linkc.4810-70103C>T intron_variant Intron 10 of 10 XP_024306541.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
RPRMLENST00000322329.5 linkc.55G>A p.Gly19Ser missense_variant Exon 1 of 1 6 NM_203400.5 ENSP00000318032.3 Q8N4K4
ENSG00000262633ENST00000571841.1 linkn.676+12327C>T intron_variant Intron 7 of 9 5 ENSP00000461460.1 E7EQ34

Frequencies

GnomAD3 genomes
AF:
0.000493
AC:
75
AN:
151982
Hom.:
1
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00179
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.000479
GnomAD2 exomes
AF:
0.0000338
AC:
2
AN:
59224
AF XY:
0.0000286
show subpopulations
Gnomad AFR exome
AF:
0.00295
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000415
AC:
54
AN:
1302000
Hom.:
0
Cov.:
32
AF XY:
0.0000405
AC XY:
26
AN XY:
641824
show subpopulations
African (AFR)
AF:
0.00188
AC:
48
AN:
25544
American (AMR)
AF:
0.0000475
AC:
1
AN:
21042
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
22172
East Asian (EAS)
AF:
0.00
AC:
0
AN:
28080
South Asian (SAS)
AF:
0.00
AC:
0
AN:
69626
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
33160
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4110
European-Non Finnish (NFE)
AF:
9.57e-7
AC:
1
AN:
1044430
Other (OTH)
AF:
0.0000743
AC:
4
AN:
53836
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.494
Heterozygous variant carriers
0
4
8
11
15
19
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000493
AC:
75
AN:
152090
Hom.:
1
Cov.:
33
AF XY:
0.000538
AC XY:
40
AN XY:
74374
show subpopulations
African (AFR)
AF:
0.00178
AC:
74
AN:
41516
American (AMR)
AF:
0.00
AC:
0
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5138
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4828
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10594
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
292
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
67934
Other (OTH)
AF:
0.000474
AC:
1
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.487
Heterozygous variant carriers
0
5
10
16
21
26
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000260
Hom.:
0
Bravo
AF:
0.000627

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
May 07, 2024
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.55G>A (p.G19S) alteration is located in exon 1 (coding exon 1) of the RPRML gene. This alteration results from a G to A substitution at nucleotide position 55, causing the glycine (G) at amino acid position 19 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.087
BayesDel_addAF
Benign
-0.45
T
BayesDel_noAF
Benign
-0.46
CADD
Benign
19
DANN
Uncertain
1.0
DEOGEN2
Benign
0.0013
T
Eigen
Benign
-0.95
Eigen_PC
Benign
-0.94
FATHMM_MKL
Benign
0.31
N
LIST_S2
Benign
0.48
T
M_CAP
Benign
0.069
D
MetaRNN
Benign
0.011
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
1.1
L
PhyloP100
1.3
PrimateAI
Uncertain
0.72
T
PROVEAN
Benign
-0.81
N
REVEL
Benign
0.032
Sift
Benign
0.039
D
Sift4G
Pathogenic
0.0
D
Polyphen
0.0010
B
Vest4
0.26
MutPred
0.34
Gain of glycosylation at G19 (P = 7e-04);
MVP
0.014
MPC
2.2
ClinPred
0.053
T
GERP RS
0.85
PromoterAI
-0.041
Neutral
Varity_R
0.083
gMVP
0.37
Mutation Taster
=93/7
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs529201942; hg19: chr17-45056319; API